SELLAS Life Sciences Group, Inc. SLS Accrued Liabilities, Current
Accrued Liabilities, Current at other companies
Other financials
Where this comes from
Reported directly by SELLAS Life Sciences Group, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The official record: SELLAS Life Sciences Group, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about SELLAS Life Sciences Group, Inc.'s accrued liabilities, current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is SELLAS Life Sciences Group, Inc.'s accrued liabilities, current?
- SELLAS Life Sciences Group, Inc. (SLS) reported accrued liabilities, current of $2.26M in Q1 2026.
- How has SELLAS Life Sciences Group, Inc.'s accrued liabilities, current changed year-over-year?
- SELLAS Life Sciences Group, Inc.'s accrued liabilities, current decreased by 12.1% year-over-year, from $2.57M to $2.26M.
- What is the long-term trend for SELLAS Life Sciences Group, Inc.'s accrued liabilities, current?
- Over 5 years (2020 to 2025), SELLAS Life Sciences Group, Inc.'s accrued liabilities, current has grown at a 13.0% compound annual growth rate (CAGR), from $1.91M to $3.53M.